Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Considering Eligibility for Studies of Deep Brain Stimulation for Treatment-Resistant Depression: Insights From a Clinical Trial in Unipolar and Bipolar Depression.

Filkowski MM, Mayberg HS, Holtzheimer PE.

J ECT. 2016 Jun;32(2):122-6. doi: 10.1097/YCT.0000000000000281.

PMID:
26479487
2.

Managing inadequate antidepressant response in depressive illness.

Haddad PM, Talbot PS, Anderson IM, McAllister-Williams RH.

Br Med Bull. 2015 Sep;115(1):183-201. doi: 10.1093/bmb/ldv034. Epub 2015 Aug 26. Review.

PMID:
26311502
3.

Treatment-resistant depression: are animal models of depression fit for purpose?

Willner P, Belzung C.

Psychopharmacology (Berl). 2015 Oct;232(19):3473-95. doi: 10.1007/s00213-015-4034-7. Epub 2015 Aug 21. Review.

PMID:
26289353
4.

Antidepressant-like Effects of Medial Forebrain Bundle Deep Brain Stimulation in Rats are not Associated With Accumbens Dopamine Release.

Bregman T, Reznikov R, Diwan M, Raymond R, Butson CR, Nobrega JN, Hamani C.

Brain Stimul. 2015 Jul-Aug;8(4):708-13. doi: 10.1016/j.brs.2015.02.007. Epub 2015 Mar 10.

PMID:
25835354
5.

Novel therapeutic strategies in major depression: focus on RNAi and ketamine.

Bortolozzi A, Celada P, Artigas F.

Curr Pharm Des. 2014;20(23):3848-60. Review.

PMID:
24180396
6.

Developments in the field of antidepressants, where do we go now?

Artigas F.

Eur Neuropsychopharmacol. 2015 May;25(5):657-70. doi: 10.1016/j.euroneuro.2013.04.013. Epub 2013 May 22.

PMID:
23706576
7.

Rapid effects of deep brain stimulation for treatment-resistant major depression.

Schlaepfer TE, Bewernick BH, Kayser S, Mädler B, Coenen VA.

Biol Psychiatry. 2013 Jun 15;73(12):1204-12. doi: 10.1016/j.biopsych.2013.01.034. Epub 2013 Apr 3. Review.

PMID:
23562618
8.

Deep brain stimulation in treatment-resistant depression in mice: comparison with the CRF1 antagonist, SSR125543.

Dournes C, Beeské S, Belzung C, Griebel G.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jan 10;40:213-20.

PMID:
23367508
9.

Behavioral and neurobiological effects of deep brain stimulation in a mouse model of high anxiety- and depression-like behavior.

Schmuckermair C, Gaburro S, Sah A, Landgraf R, Sartori SB, Singewald N.

Neuropsychopharmacology. 2013 Jun;38(7):1234-44. doi: 10.1038/npp.2013.21. Epub 2013 Jan 16.

10.

[Treatment resistant depression: therapy and novel neuromodulatory treatments].

Kosel M, Berney A.

Rev Med Suisse. 2012 May 2;8(339):942-5. Review. French.

PMID:
22675825
11.

Frontal theta cordance predicts 6-month antidepressant response to subcallosal cingulate deep brain stimulation for treatment-resistant depression: a pilot study.

Broadway JM, Holtzheimer PE, Hilimire MR, Parks NA, Devylder JE, Mayberg HS, Corballis PM.

Neuropsychopharmacology. 2012 Jun;37(7):1764-72. doi: 10.1038/npp.2012.23. Epub 2012 Mar 14.

12.

The hidden third: improving outcome in treatment-resistant depression.

Schlaepfer TE, Agren H, Monteleone P, Gasto C, Pitchot W, Rouillon F, Nutt DJ, Kasper S.

J Psychopharmacol. 2012 May;26(5):587-602. doi: 10.1177/0269881111431748. Epub 2012 Jan 11. Review.

PMID:
22236505
13.

Neurostimulation therapies for treatment resistant depression: a focus on vagus nerve stimulation and deep brain stimulation.

Rizvi SJ, Donovan M, Giacobbe P, Placenza F, Rotzinger S, Kennedy SH.

Int Rev Psychiatry. 2011 Oct;23(5):424-36. doi: 10.3109/09540261.2011.630993. Review.

PMID:
22200132
14.

A multicenter pilot study of subcallosal cingulate area deep brain stimulation for treatment-resistant depression.

Lozano AM, Giacobbe P, Hamani C, Rizvi SJ, Kennedy SH, Kolivakis TT, Debonnel G, Sadikot AF, Lam RW, Howard AK, Ilcewicz-Klimek M, Honey CR, Mayberg HS.

J Neurosurg. 2012 Feb;116(2):315-22. doi: 10.3171/2011.10.JNS102122. Epub 2011 Nov 18.

PMID:
22098195
15.

The application of vagus nerve stimulation and deep brain stimulation in depression.

Mohr P, Rodriguez M, Slavíčková A, Hanka J.

Neuropsychobiology. 2011;64(3):170-81. doi: 10.1159/000325225. Epub 2011 Jul 29. Review.

16.

Therapeutic options in treatment-resistant depression.

Vieta E, Colom F.

Ann Med. 2011 Nov;43(7):512-30. doi: 10.3109/07853890.2011.583675. Epub 2011 May 31. Review.

PMID:
21623700
17.

The emerging use of technology for the treatment of depression and other neuropsychiatric disorders.

Howland RH, Shutt LS, Berman SR, Spotts CR, Denko T.

Ann Clin Psychiatry. 2011 Feb;23(1):48-62. Review.

PMID:
21318196
18.

Neurogenic hippocampal targets of deep brain stimulation.

Encinas JM, Hamani C, Lozano AM, Enikolopov G.

J Comp Neurol. 2011 Jan 1;519(1):6-20. doi: 10.1002/cne.22503.

19.

Therapeutic options for treatment-resistant depression.

Shelton RC, Osuntokun O, Heinloth AN, Corya SA.

CNS Drugs. 2010 Feb;24(2):131-61. doi: 10.2165/11530280-000000000-00000. Review.

PMID:
20088620
20.

Treatment resistant depression as a failure of brain homeostatic mechanisms: implications for deep brain stimulation.

Giacobbe P, Mayberg HS, Lozano AM.

Exp Neurol. 2009 Sep;219(1):44-52. doi: 10.1016/j.expneurol.2009.04.028. Epub 2009 May 6. Review.

PMID:
19426730

Supplemental Content

Loading ...
Support Center